Open access peer-reviewed chapter

Advanced Models for Target Validation & Drug Discovery in Prostate Cancer

By Malin Åkerfelt, Ville Härmä and Matthias Nees

Submitted: January 28th 2011Reviewed: August 26th 2011Published: November 25th 2011

DOI: 10.5772/25629

Downloaded: 1491

© 2011 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Malin Åkerfelt, Ville Härmä and Matthias Nees (November 25th 2011). Advanced Models for Target Validation & Drug Discovery in Prostate Cancer, Prostate Cancer Philippe E. Spiess, IntechOpen, DOI: 10.5772/25629. Available from:

Embed this chapter on your site Copy to clipboard

<iframe src="" />

Embed this code snippet in the HTML of your website to show this chapter

chapter statistics

1491total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Signalling Pathways and Gene Expression Profiles in Prostate Cancer

By Sophia Marsella-Hatziieremia, Pamela McCall and Joanne Edwards

Related Book

First chapter

Biomarkers of Aggressiveness in Prostate Cancer

By Cuvillier Olivier and Malavaud Bernard

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

+3,550 Open Access Books

+57,400 Citations in Web of Science

+108,500 IntechOpen Authors and Academic Editors

+560,000 Unique visitors per month

More about us